CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,185,988
- in 8 filings, $4.8M under 10b5-1 plans
Net −$5,185,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −674 | $75.84 | $51K | 144,072 |
| 2024-07-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −634 | $76.86 | $49K | 143,438 |
| 2024-07-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −751 | $75.92 | $57K | 143,995 |
| 2024-07-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −557 | $76.89 | $43K | 143,438 |
| 2024-06-24 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Option exercise 10b5-1 | +15,000 | $2.03 | $30K | 493,888 |
| 2024-06-24 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −10,341 | $75.39 | $780K | 483,547 |
| 2024-06-24 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −4,471 | $76.17 | $341K | 479,076 |
| 2024-06-24 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −188 | $76.80 | $14K | 478,888 |
| 2024-06-24 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | +15,000 | 197,327 | ||
| 2024-06-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise 10b5-1 | +8,000 | $5.35 | $43K | 104,720 |
| 2024-06-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale 10b5-1 | −7,652 | $71.89 | $550K | 97,068 |
| 2024-06-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale 10b5-1 | −348 | $72.56 | $25K | 96,720 |
| 2024-06-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise · Stock Option (right to buy) 10b5-1 | −8,000 | 344,827 | ||
| 2024-06-07 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Shares withheld for taxes | −335 | $70.97 | $24K | 30,826 |
| 2024-06-06 | Lee Jacks Director | Grant or award | +1,550 | 1,550 | ||
| 2024-06-06 | Lee Jacks Director | Grant or award · Stock Option (right to buy) | +7,250 | 7,250 | ||
| 2024-06-06 | Loxam Teri Director | Grant or award | +1,550 | 7,175 | ||
| 2024-06-06 | Loxam Teri Director | Grant or award · Stock Option (right to buy) | +7,250 | 7,250 | ||
| 2024-06-06 | Gilbert Halley E Director | Grant or award | +1,550 | 7,175 | ||
| 2024-06-06 | Gilbert Halley E Director | Grant or award · Stock Option (right to buy) | +7,250 | 7,250 |
Page 26 of 39 · 764 trades